High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg) treatment in acute myeloid leukemia patients. (Q47929658)
Jump to navigation
Jump to search
scientific article published in May 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg) treatment in acute myeloid leukemia patients. |
scientific article published in May 2004 |
Statements
1 reference
High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg) treatment in acute myeloid leukemia patients. (English)
1 reference
V H J van der Velden
1 reference
N Boeckx
1 reference
I Jedema
1 reference
J G te Marvelde
1 reference
P G Hoogeveen
1 reference
M Boogaerts
1 reference
J J M van Dongen
1 reference
1 May 2004
1 reference
1 reference
18
1 reference
5
1 reference
983-988
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference